Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
  1. 4 Open-market sale See Remarks sold 2,306 shares at $6.27 ($14,453)
  2. 4 Open-market sale Chief Human Resources Officer sold 1,846 shares at $6.27 ($11,570)
  3. 4 Open-market sale Chief Commercial Officer sold 7,998 shares at $6.27 ($50,127)
  4. 4 Open-market sale Chief Business Officer sold 7,248 shares at $6.27 ($45,427)
  5. 4 Open-market sale Chief Patient Officer sold 6,989 shares at $6.27 ($43,804)
  6. 4 Open-market sale President & CEO sold 54,748 shares at $6.27 ($343,133)
  7. 4 Planned sale President & CEO sold 41,666 shares at $6.28 ($261,612)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Planned sale President & CEO sold 41,668 shares at $6.29 ($261,954)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Planned sale President & CEO sold 41,666 shares at $5.84 ($243,329)
  12. 4 Planned sale President & CEO sold 41,666 shares at $6.26 ($260,621)
  13. 4 Open-market buy Director bought 333,333 shares at $5.84 ($1,946,331)
  14. 4 Open-market sale See Remarks sold 3,179 shares at an average $5.85 ($18,586)
  15. 4 Open-market sale See Remarks sold 4,991 shares at an average $5.85 ($29,181)
  16. 4 Open-market sale See Remarks sold 8,176 shares at an average $5.85 ($47,803)
  17. 4 Open-market sale Chief Financial Officer sold 2,033 shares at an average $5.85 ($11,886)
  18. 4 Open-market sale Chief Human Resources Officer sold 2,543 shares at an average $5.85 ($14,868)
  19. 4 Open-market sale See Remarks sold 9,595 shares at an average $5.85 ($56,099)
  20. 4 Open-market sale President & CEO sold 45,982 shares at an average $5.85 ($268,841)

Page 2 of 35 · 690 filings